EIDD-2749, a RdRp Inhibitor, is a Promising Candidate for COVID-19 Oral Therapy
COVID-19 is an infectious disease caused by the coronavirus (SARS-CoV-2), which mainly causes symptoms such as fever and cough. It spreads through droplet transmission or contact transmission. Since 2019, COVID-19…